27583405|t|Establishment of a Flexible Real-Time Polymerase Chain Reaction -Based Platform for Detecting Prevalent Deafness Mutations Associated with Variable Degree of Sensorineural Hearing Loss in Koreans
27583405|a|Many cutting-edge technologies based on next-generation sequencing (NGS) have been employed to identify candidate variants responsible for sensorineural hearing loss (SNHL). However, these methods have limitations preventing their wide clinical use for primary screening, in that they remain costly and it is not always suitable to analyze massive amounts of data. Several different DNA chips have been developed for screening prevalent mutations at a lower cost. However, most of these platforms do not offer the flexibility to add or remove target mutations, thereby limiting their wider use in a field that requires frequent updates. Therefore, we aimed to establish a simpler and more flexible molecular diagnostic platform based on ethnicity -specific mutation spectrums of SNHL, which would enable bypassing unnecessary filtering steps in a substantial portion of cases. In addition, we expanded the screening platform to cover varying degrees of SNHL. With this aim, we selected 11 variants of 5 genes (GJB2, SLC26A4, MTRNR1, TMPRSS3, and CDH23) showing high prevalence with varying degrees in Koreans and developed the U-TOP™ HL Genotyping Kit, a real-time PCR -based method using the MeltingArray technique and peptide nucleic acid probes. The results of 271 DNA samples with wild type sequences or mutations in homo- or heterozygote form were compared between the U-TOP™ HL Genotyping Kit and Sanger sequencing. The positive and negative predictive values were 100%, and this method showed perfect agreement with Sanger sequencing, with a Kappa value of 1.00. The U-TOP™ HL Genotyping Kit showed excellent performance in detecting varying degrees and phenotypes of SNHL mutations in both homozygote and heterozygote forms, which are highly prevalent in the Korean population. This platform will serve as a useful and cost-effective first-line screening tool for varying degrees of genetic SNHL and facilitate genome -based personalized hearing rehabilitation for the Korean population.
27583405	19	27	Flexible	T080	C0443220
27583405	28	63	Real-Time Polymerase Chain Reaction	T063	C1709846
27583405	71	79	Platform	T075	C1710360
27583405	84	93	Detecting	T033	C0442726
27583405	94	103	Prevalent	T081	C0220900
27583405	104	112	Deafness	T033	C0011053
27583405	113	122	Mutations	T045	C0026882
27583405	123	138	Associated with	T080	C0332281
27583405	139	147	Variable	T080	C0439828
27583405	148	154	Degree	T080	C0441889
27583405	158	184	Sensorineural Hearing Loss	T047	C0018784
27583405	188	195	Koreans	T098	C1556095
27583405	201	226	cutting-edge technologies	T063	C0814038
27583405	236	262	next-generation sequencing	T063	C2936622
27583405	264	267	NGS	T063	C2936622
27583405	291	299	identify	T033	C0243095
27583405	300	309	candidate	T098	C1257890
27583405	310	318	variants	T028	C0678941
27583405	335	361	sensorineural hearing loss	T047	C0018784
27583405	363	367	SNHL	T047	C0018784
27583405	385	392	methods	T169	C0449851
27583405	398	409	limitations	T169	C0449295
27583405	410	420	preventing	T169	C1292733
27583405	432	440	clinical	T080	C0205210
27583405	441	444	use	T169	C0457083
27583405	449	456	primary	T080	C0205225
27583405	457	466	screening	T058	C0220908
27583405	488	494	costly	T169	C0220812
27583405	528	535	analyze	T169	C1524024
27583405	536	551	massive amounts	T081	C1265611
27583405	555	559	data	T078	C1511726
27583405	579	588	DNA chips	T075	C0600596
27583405	613	622	screening	T058	C0220908
27583405	623	632	prevalent	T081	C0220900
27583405	633	642	mutations	T045	C0026882
27583405	654	658	cost	T081	C0010186
27583405	683	692	platforms	T075	C1710360
27583405	710	721	flexibility	T080	C0443220
27583405	725	728	add	T169	C1883712
27583405	732	738	remove	T052	C1883720
27583405	739	745	target	T169	C1521840
27583405	746	755	mutations	T045	C0026882
27583405	786	789	use	T169	C0457083
27583405	885	893	flexible	T080	C0443220
27583405	894	923	molecular diagnostic platform	T063	C0949688
27583405	933	942	ethnicity	T080	C0243103
27583405	953	961	mutation	T045	C0026882
27583405	962	971	spectrums	T080	C0205556
27583405	975	979	SNHL	T047	C0018784
27583405	1022	1037	filtering steps	T077	C1261552
27583405	1066	1071	cases	T077	C1706256
27583405	1102	1120	screening platform	T058	C0220908
27583405	1130	1137	varying	T080	C0439828
27583405	1138	1145	degrees	T080	C0441889
27583405	1149	1153	SNHL	T047	C0018784
27583405	1185	1193	variants	T028	C0678941
27583405	1199	1204	genes	T028	C0017337
27583405	1206	1210	GJB2	T028	C1415077
27583405	1212	1219	SLC26A4	T028	C1418445
27583405	1221	1227	MTRNR1	T028	C1537996
27583405	1229	1236	TMPRSS3	T028	C1420784
27583405	1242	1247	CDH23	T028	C1422171
27583405	1262	1272	prevalence	T081	C0220900
27583405	1278	1285	varying	T080	C0439828
27583405	1286	1293	degrees	T080	C0441889
27583405	1297	1304	Koreans	T098	C1556095
27583405	1323	1347	U-TOP™ HL Genotyping Kit	T074	C0812225
27583405	1351	1364	real-time PCR	T063	C1709846
27583405	1372	1378	method	T169	C0449851
27583405	1389	1411	MeltingArray technique	T062	C0035177
27583405	1416	1436	peptide nucleic acid	T114	C0600500
27583405	1437	1443	probes	T074	C0182400
27583405	1464	1475	DNA samples	T026	C0444245
27583405	1481	1490	wild type	T028	C1883559
27583405	1491	1500	sequences	T086	C0162326
27583405	1504	1513	mutations	T045	C0026882
27583405	1517	1522	homo-	T032	C0019904
27583405	1526	1543	heterozygote form	T032	C0019425
27583405	1570	1594	U-TOP™ HL Genotyping Kit	T074	C0812225
27583405	1599	1616	Sanger sequencing	T063	C1511897
27583405	1622	1630	positive	T033	C1446409
27583405	1635	1643	negative	T033	C0205160
27583405	1644	1661	predictive values	T081	C0032944
27583405	1682	1688	method	T169	C0449851
27583405	1719	1736	Sanger sequencing	T063	C1511897
27583405	1745	1750	Kappa	T170	C0439099
27583405	1751	1756	value	T081	C1522609
27583405	1770	1794	U-TOP™ HL Genotyping Kit	T074	C0812225
27583405	1827	1836	detecting	T033	C0442726
27583405	1837	1844	varying	T080	C0439828
27583405	1845	1852	degrees	T080	C0441889
27583405	1857	1867	phenotypes	T032	C0031437
27583405	1871	1875	SNHL	T047	C0018784
27583405	1876	1885	mutations	T045	C0026882
27583405	1894	1904	homozygote	T032	C0019904
27583405	1909	1927	heterozygote forms	T032	C0019425
27583405	1946	1955	prevalent	T081	C0220900
27583405	1963	1980	Korean population	T098	C1556095
27583405	1987	1995	platform	T075	C1710360
27583405	2012	2018	useful	T169	C0457083
27583405	2023	2037	cost-effective	T169	C0220812
27583405	2038	2063	first-line screening tool	T170	C0282574
27583405	2068	2075	varying	T080	C0439828
27583405	2076	2083	degrees	T080	C0441889
27583405	2087	2094	genetic	T169	C0314603
27583405	2095	2099	SNHL	T047	C0018784
27583405	2115	2121	genome	T028	C0017428
27583405	2129	2164	personalized hearing rehabilitation	T058	C3489530
27583405	2173	2190	Korean population	T098	C1556095